Real World Evaluation of Lunit INSIGHT MMG Technology
Launched by LUNIT INC. · Jan 22, 2024
Trial Information
Current as of June 26, 2025
Not yet recruiting
Keywords
ClinConnect Summary
This clinical trial is studying a new technology called Lunit INSIGHT MMG, which helps radiologists read mammograms for breast cancer and other breast diseases. The goal is to see if using this tool alongside a human reader is just as effective as the current standard practice, where two human readers review the images. The trial will take place in a one-stop breast clinic, where patients can have their mammograms and get results quickly. By comparing the two methods, the researchers hope to find out if the Lunit tool can help improve efficiency without compromising patient care.
To participate in the trial, women aged 18 and older who have been referred to the clinic for breast symptoms may be eligible. However, men and women who can’t tolerate a mammogram due to physical difficulties will not be included. Participants can expect to undergo standard mammography procedures, and their results will help determine if the new technology can be safely used in the future. It's important to note that this study is not yet recruiting participants, but it aims to maintain high-quality care for all patients while exploring new ways to improve the mammography process.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • Non-Inferiority Study
- • Women 18 years of age or older.
- • Referred to a "one-stop" breast clinic following GP appointment for breast symptoms.
- • Patient and workforce qualitative studies Patients: as above. Workforce: Clinical staff and other key stakeholders involved in the implementation of Lunit INSIGHT MMG both male and female
- • • Able to undergo mammography.
- Exclusion Criteria:
- • Non-Inferiority Study
- • Men will not be included in this study.
- • Women who are not able to tolerate a mammogram or are unable to have one due to physical difficulties in engagement with the technology caused by immobility or being wheelchair bound.
- • Patient and workforce qualitative studies Patients: as above. Workforce: Has no connection to Lunit INSIGHT MMG implementation irrespective of being male or female
About Lunit Inc.
Lunit Inc. is a leading healthcare technology company specializing in artificial intelligence for medical imaging and diagnostics. Focused on enhancing cancer detection and treatment, Lunit develops innovative AI-powered solutions that assist healthcare professionals in making more accurate and timely decisions. The company is committed to advancing precision medicine through its cutting-edge research and clinical trials, aiming to improve patient outcomes and streamline workflows in clinical settings. With a strong emphasis on collaboration and scientific rigor, Lunit Inc. is at the forefront of transforming healthcare through technology.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Leeds, , United Kingdom
Patients applied
Trial Officials
Nisha Sharma
Principal Investigator
The Leeds Teaching Hospital NHS Trust
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported